Systemic Hormone Therapy During Menopause May Up Risk for Depression

FRIDAY, Nov. 4, 2022 -- Systemically administered hormone therapy (HT) during menopause is associated with a higher risk for depression, according to a study published online Nov. 1 in JAMA Network Open. Marie K. Wium-Andersen, M.D., Ph.D., from...
Source: Drugs.com - Pharma News - Category: Pharmaceuticals Source Type: news